Abstract
The rapid adoption of machine learning (ML) algorithms in medical disciplines has raised concerns about trust and the lack of understanding of their results. Efforts are being made to develop more interpretable models and establish guidelines for transparency and ethical use, ensuring the responsible integration of machine learning in healthcare. In this study we use two ML interpretability methods to gain insights into the dynamics of brain network interactions in epilepsy, a neurological disorder increasingly viewed as a network disorder that affects more than 60 million persons worldwide. Using high-resolution intracranial electroencephalogram (EEG) recordings from a cohort of 16 patients, combined with high-accuracy ML algorithms, we classify EEG recordings into binary classes of seizure and non-seizure, as well as multiple classes corresponding to different phases of a seizure. This study demonstrates, for the first time, that ML interpretability methods can provide new insights into the dynamics of aberrant brain networks in neurological disorders such as epilepsy. Moreover, we show that interpretability methods can effectively identify key brain regions and network connections involved in the disruptions of brain networks, such as those that occur during seizure events. These findings emphasize the importance of continued research into the integration of ML algorithms and interpretability methods in medical disciplines and enable the discovery of new insights into the dynamics of aberrant brain networks in epilepsy patient.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded in part by the grants from the US National Institutes of Health (NIH): U24EB029005, R01DA053028, the US Department of Defense (DoD) grant#W81XWH2110859, Dravet Syndrome Foundation (DSF), and the Clinical and Translational Science Collaborative of Cleveland, which is funded by the NIHNCATS, Clinical and Translational Science Award grant, UL1TR002548. The content is solely the responsibility of the authors and does not necessarily represent the official views of the respective funding agencies.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee of University Hospitals Cleveland Medical Center.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The individual patient records cannot be made publicly available due to regulatory reasons.
